<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775060</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 08-3-066</org_study_id>
    <nct_id>NCT00775060</nct_id>
  </id_info>
  <brief_title>Maastricht IBS Cohort</brief_title>
  <official_title>Maastricht IBS Cohort: Phenotypical and Genotypical Characterization of Patients With Irritable Bowel Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To set up a cohort of at least 400 IBS patients in order to identify different patient&#xD;
      subgroups according to phenotypical and genotypical patterns and&#xD;
&#xD;
      To set up a biobank for future translational studies on the pathophysiology of IBS, in order&#xD;
      to identify genetic factors to unravel the pathogenesis of IBS and to provide novel&#xD;
      therapeutic targets.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the present study is to set up a large cohort of IBS patients in order to identify&#xD;
      different disease characteristics as well as aetiological and pathophysiological factors in&#xD;
      (sub)groups of patients with this heterogeneous disorder. Various phenotypical and&#xD;
      genotypical markers will be evaluated. For this purpose, blood and faecal samples as well as&#xD;
      symptom questionnaires will be collected and visceral perception and intestinal permeability&#xD;
      will be measured. In order to increase the sensitivity of the barostat procedure, a pilot&#xD;
      study will be performed by measuring patients and healthy controls under meal stimulated and&#xD;
      fasting conditions. We aim to set up a biobank for studies on the pathophysiology of IBS, in&#xD;
      order to identify genetic factors that may help unravel the pathogenesis of IBS and provide&#xD;
      novel therapeutic targets. Consent will be asked to collect data from questionnaires, to&#xD;
      store serum samples, DNA, stool and, when endoscopy is performed for clinical reasons, also&#xD;
      biopsy specimens.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        At least 400 patients with (suspected) IBS referred to the GI-outpatient clinic of the&#xD;
        Maastricht University Medical Center will be asked to participate in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  IBS-patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe co-morbidity hindering a rectal barostat procedure, according to the&#xD;
             gastroenterologist's perception.&#xD;
&#xD;
          -  Abdominal surgery, except for uncomplicated appendectomy, laparoscopic cholecystectomy&#xD;
             or hysterectomy.&#xD;
&#xD;
          -  Inability to stop medication that can influence gastrointestinal motility or&#xD;
             perception (like loperamide, butylscopolamine, psylliumsead (metamucil), duspatal,&#xD;
             metoclopramide, domperidon, erytromycin and serotonin reuptake inhibitors), for at&#xD;
             least 3 days before tests.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ad Masclee, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daisy Jonkers, PhD</last_name>
    <phone>+31 43 3785021</phone>
    <email>d.jonkers@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Jonkers, PhD</last_name>
      <email>d.jonkers@maastrichtuniversity.nl</email>
    </contact>
    <investigator>
      <last_name>Daisy Jonkers, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <last_update_submitted>April 6, 2016</last_update_submitted>
  <last_update_submitted_qc>April 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

